Heikkinen M, Janatuinen E, Mayo K, Mégraud F, Julkunen R, Pikkarainen P
Department of Medicine, Kuopio University Hospital, Finland.
Am J Gastroenterol. 1997 Dec;92(12):2225-9.
Screening of dyspeptic patients with serological tests for Helicobacter pylori before open-access gastroscopy has been suggested to be worthwhile. CagA-positive H. pylori strains may be associated with major pathology more often than CagA-negative strains. The usefulness of anti-H. pylori and anti-CagA antibodies in screening for gastroscopy was evaluated in unselected dyspeptic patients.
Four hundred consecutive, unselected dyspeptic patients (mean age, 56.8 yr) in primary care were investigated with gastroscopy, ultrasonography of the upper abdomen, laboratory tests (including serological tests for H. pylori and CagA), and other examinations if needed. The patients were followed for 1 yr.
Results of serological tests were positive for H. pylori in 56.2% of patients, of whom 64.4% also had results positive for CagA. Use of H. pylori and CagA serology-based screening combined with a history of nonsteroidal anti-inflammatory drug use would have detected only 80 and 70% of the major pathologies (peptic ulcer, moderate or severe esophagitis, celiac disease, or malignancy), respectively, in these patients. Gastroscopy would have been avoided in 30 and 41%, respectively, if only patients who had positive results on serological tests or who were nonsteroidal anti-inflammatory drug users would have been referred. In patients younger than 45 yr of age (n = 87), 60-74% of gastroscopies would have been avoided, but 50-60% of major pathologies would have been missed, by using the screening strategy studied. One of the nine malignancies (all in patients >45 yr of age) was H. pylori-negative, and two were CagA-negative.
Anti-CagA antibodies do not offer advantages compared with anti-H. pylori antibodies in screening patients for gastroscopy. A remarkable share of major pathologies are missed by both of these screening methods. Therefore, the results of these screening tests are not recommended as selective criteria for gastroscopy.
有人提出,在开放式胃镜检查前,用血清学检测幽门螺杆菌来筛查消化不良患者是值得的。细胞毒素相关基因A(CagA)阳性的幽门螺杆菌菌株可能比CagA阴性菌株更常与严重病变相关。在未经挑选的消化不良患者中,评估了抗幽门螺杆菌抗体和抗CagA抗体在胃镜检查筛查中的作用。
对基层医疗中连续400例未经挑选的消化不良患者(平均年龄56.8岁)进行了胃镜检查、上腹部超声检查、实验室检查(包括幽门螺杆菌和CagA的血清学检测),并根据需要进行了其他检查。对患者进行了1年的随访。
56.2%的患者幽门螺杆菌血清学检测结果呈阳性,其中64.4%的患者CagA检测结果也呈阳性。在这些患者中,使用基于幽门螺杆菌和CagA血清学的筛查方法,结合非甾体抗炎药使用史,分别只能检测出80%和70%的严重病变(消化性溃疡、中度或重度食管炎、乳糜泻或恶性肿瘤)。如果仅转诊血清学检测结果呈阳性的患者或非甾体抗炎药使用者,分别有30%和41%的患者可避免胃镜检查。在年龄小于45岁的患者(n = 87)中,采用所研究的筛查策略,60% - 74%的胃镜检查可避免,但50% - 60%的严重病变会被漏诊。9例恶性肿瘤患者(均大于45岁)中有1例幽门螺杆菌检测为阴性,2例CagA检测为阴性。
在筛查患者进行胃镜检查时,抗CagA抗体与抗幽门螺杆菌抗体相比并无优势。这两种筛查方法都会漏诊相当一部分严重病变。因此,不建议将这些筛查试验的结果作为胃镜检查的选择标准。